Major Depressive Disorder (MDD) Clinical Trials

57 recruiting

Major Depressive Disorder (MDD) Trials at a Glance

53 actively recruiting trials for major depressive disorder (mdd) are listed on ClinicalTrialsFinder across 6 cities in 25 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Toronto, Gdansk, and New York. Lead sponsors running major depressive disorder (mdd) studies include Emobot, IRCCS Centro San Giovanni di Dio Fatebenefratelli, and Shanghai Mental Health Center.

Browse major depressive disorder (mdd) trials by phase

Treatments under study

About Major Depressive Disorder (MDD) Clinical Trials

Looking for clinical trials for Major Depressive Disorder (MDD)? There are currently 57 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Major Depressive Disorder (MDD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Major Depressive Disorder (MDD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Phase 2

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)
Draig Therapeutics Ltd300 enrolled40 locationsNCT07300969
Recruiting
Phase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+7 more
Yale University200 enrolled2 locationsNCT06624137
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting
Early Phase 1

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

Major Depressive Disorder (MDD)
University of Pennsylvania10 enrolled1 locationNCT06788249
Recruiting
Phase 2

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc.153 enrolled13 locationsNCT07284667
Recruiting
Phase 2

Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder

Major Depressive Disorder (MDD)
Roger McIntyre30 enrolled1 locationNCT07523048
Recruiting

Gender Differences in Depression Severity, Gender-Sensitive Symptoms, Resilience, and Stigma in Major Depressive Disorder

Major Depressive Disorder (MDD)Gender Differences
Eskisehir Osmangazi University90 enrolled1 locationNCT07474363
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Major Depressive Disorder (MDD)Major Depressive Disorder With Anxious Distress
Seaport Therapeutics360 enrolled45 locationsNCT07065240
Recruiting
Not Applicable

Home-Based tDCS Treatment Of Major Depressive Disorder

Major Depressive Disorder (MDD)
Sooma Medical Inc200 enrolled1 locationNCT06976697
Recruiting
Phase 2

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Major Depressive Disorder (MDD)
Supernus Pharmaceuticals, Inc.230 enrolled1 locationNCT07226661
Recruiting
Phase 2

A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression

Major Depressive Disorder (MDD)
Daniel Lindqvist12 enrolled1 locationNCT07396272
Recruiting
Not Applicable

Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan

Breast Cancer SurvivorMajor Depressive Disorder (MDD)
Pakistan Institute of Living and Learning26,376 enrolled1 locationNCT07015944
Recruiting
Not Applicable

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk

Suicidal IdeationMajor Depressive Disorder (MDD)
University of California, Davis25 enrolled1 locationNCT07025720
Recruiting

LHC-CIDI-5 in Hong Kong

Suicidal IdeationMajor Depressive Disorder (MDD)Bipolar I Disorder+14 more
The University of Hong Kong2,500 enrolled1 locationNCT06804525
Recruiting
Not Applicable

NUTRIBRAIN: Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRactice (POWER)

Major Depressive Disorder (MDD)
National Science and Technology Council, Taiwan120 enrolled1 locationNCT07462013
Recruiting
Phase 3

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)
Vanda Pharmaceuticals500 enrolled38 locationsNCT06830044
Recruiting
Not Applicable

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode

Major Depressive Disorder (MDD)
Emobot104 enrolled11 locationsNCT06601140
Recruiting

VR Pupillometry in Cognitive Impairment

DementiaMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry140 enrolled1 locationNCT07402356
Recruiting
Phase 4

The Role of mGluR5 in CBT-I

Major Depressive Disorder (MDD)
Stony Brook University42 enrolled1 locationNCT07076342